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Abstract
Located in the vertebral column, the human spine is responsible for
regulating body movements and receiving sensory input about pain and touch.
Currently, few treatments for neurological diseases and spinal cord injuries exist,
partly because we know little about how a fully functioning spinal cord is
constructed. As such, studying spinal cord development, specifically neuronal
specification and patterning, should be useful for developing better treatments for
people with spinal cord injuries and diseases. Zebrafish are a prime model
organism for studying neuronal specification because their transparent embryos
develop outside the mother, allowing us to easily examine gene expression, cell
movements and cell morphology during development . Furthermore, the zebrafish
spinal cord has few types of interneurons compared to mammals, and each
interneuron type can be recognized by its distinct morphology.
I focused on V1 cells, which form in the ventral spinal cord and are
functionally similar in all vertebrates. In zebrafish, V1 cells develop into CiAs, or
Cicumferential Ascending interneurons, which control movement and sensory
gating. Several transcription factors are expressed consistently in all vertebrate V1
cells, and my research focused on Lhx1a, Lhx1b and Lhx5. As a result of findings
in mice, I predicted that knocking down these transcription factors would result in
neurotransmitter deficits and potentially compromise movement ability.
Additionally, a main focus of my project became assaying various experimental
strategies for knocking-down Lhx1a, Lhx1b and Lhx5. These included injecting
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reagents into 1-4 cell stage embryos and taking advantage of a lhx1b mutant fish
line. For the injections, I used morpholinos (MOs), antisense agents that either
interfere with RNA transcription to protein or with RNA splicing. I also used
RNA constructs which should act as either dominant activators or dominant
repressors. Using in situ hybridization, I then tried to assess the impact on
neurotransmitters throughout the spinal cord and specifically within CiAs.
I successfully identified a PCR and restriction enzyme digest method for
identifying lhx1b mutants. This was exciting as it was a completely novel method
for identifying these fish. Furthermore, my results demonstrated that homozygous
lhx1b mutants are viable which was previously unknown. My injection results
demonstrate that lhx1b and lhx5 splice-blocking MOs are also an effective tool for
knocking-down the function of these two genes. In contrast, the lhx1a MOs that I
tried were not effective. My RNA injection results were inconclusive and I
determined that a higher concentration was probably needed to impact Lhx1 and
Lhx5 function.
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Introduction
Located in the vertebral column, the human spine is responsible for
controlling many bodily functions that healthy individuals take for granted. In
addition to regulating standard body movements and organ operations, the spinal
cord receives sensory input about pain and touch from the rest of the body.
Various neurological conditions including neuro-degeneration as well as spinal
cord injuries result in deficits in these functions. These types of ailments are
particularly common. A recent survey estimated that 183,000-230,000 people in
the United States alone suffer from spinal cord injuries (NIH Medline Plus).
Furthermore, approximately 11,000 new cases of spinal cord injury present each
year in the United States (NIH Medline Plus). Oftentimes these injuries are the
result of accidents, violence, and sports-related injuries and happen to people in
the prime of their life (NIH Medline Plus). Currently, there are few treatments for
these conditions, partly because we know very little about how a fully functioning
spinal cord is constructed. As such, studying spinal cord development,
specifically neuronal specification and patterning, can ultimately be useful for
developing better treatments for people with spinal cord injuries and diseases.
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Zebrafish are a powerful
model organism in which to
study neuronal specification for
a

number

of

reasons.

example,

zebrafish

relatively

inexpensive

For

are

a

choice

when compared to other Figure 1. Depicting rapid development of a zebrafish
vertebrates and a large
quantity of embryos can
be easily obtained from

embryo. Blue arrow indicates cells in early embryo. Red
arrows indicate chorion which surrounds embryo
during early development. Orange arrow indicates yolk
which provides nutrients to embryo during early
development. Yellow arrow indicates zebrafish head.
Based on figure by Dr. Lewis.

adult fish without harming the parents. In addition, zebrafish have transparent
embryos that grow rapidly outside of the mother (figure 1). These characteristics
allow us to examine central nervous system (CNS) development, including spinal
cord development, in
live embryos. In some
instances, being able to
visually examine CNS
development

Figure 2. Absence of mid-brain hindbrain boundary in noi
mutants at 28 hours post-fertilization. Red arrows shows
midbrain/hindbrain boundary (or absence in H). Figure
taken from Molina et al. (2007).

embryos

in

live

becomes
particularly

imperative.

For

instance, some mutations cause characteristic morphological phenotypes that can
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be readily viewed during embryonic development. The transparency of zebrafish
embryos enables us to identify mutants and separate them from wild-type
embryos. An example of this is noi (no-isthmus) mutants, in which the mid-brain
hindbrain boundary does not form. As shown in figure 2, the mutants can readily
be identified because of their characteristic lack of this boundary.
Zebrafish are also a useful model organism because interneuron
morphology can be examined in live embryos. This can be accomplished by
labeling
specific cell
types

with

fluorescent
proteins such
as GFP. It is
difficult

to

observe
embryonic
interneurons
Figure 3. Schematic showing the unique morphologies and
neurotransmitter fates of zebrafish interneurons. Anterior is to
the left. Dotted line= contralateral axons. Solid line= ipsiliateral
axons. Figure based on a figure from Lewis and Eisen (2003) and
information from Higashijima (2004).

in

some vertebrate,
particularly
mammals.

This

is because mammalian embryos develop inside the mother and are not transparent.
It is easier to study interneurons and identify them as a particular cell type with a
specific function in zebrafish. This is because, in addition to being able to
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visualize individual interneurons in the externally-developing transparent
zebrafish embryos, the zebrafish spinal cord has relatively few different types of
interneurons in comparison to mammals. Furthermore, each interneuron type can
be easily recognized by its particular morphology, as seen in figure 3. For
example, the interneuron type I studied, Circumferential Ascending (CiA)
interneurons, have a distinct interneuron shape which distinguishes them from the
others as seen in figure 3.

In addition to the unique morphologies, each

interneuron type has a distinct neurotransmitter fate. Neurotransmitters are the
chemicals within the central nervous system that help neurons to communicate.
Finally, it is easy to knock down individual gene functions with mutants and other
methods in zebrafish which was particularly important for my project. A primary
method used in this project was injections into 1-2 cell stage embryos, where I
injected various reagents into an embryo via a thin needle. The transparency and
rapid development of zebrafish embryos enables this experimental technique to be
utilized relatively easily.
This project focused on V1 neurons which form in the ventral spinal cord.
During spinal cord development, cells originate in distinct dorsal-ventral
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Cell Population

Function

V0

Control side-to-side motion during
movement

V1

Regulate/enable fast movements

V2

Alternation during rapid movement,
rhythm generation

V3

Rhythm during locomotion

Figure 4. Table listing the different functions of ventral cell populations. Figure
created based on information in Goulding (2009).

progenitor domains and migrate laterally to specific dorsal-ventral post-mitotic
domains (figure 5). In both regions, individual cells take on a particular identity
depending on their dorsal-ventral location in the spinal cord. This dorsal-ventral
identity then leads cells to develop into distinct interneuron types with unique
characteristics functions. For instance, distinct ventral interneurons control
different aspects of movement as indicated in figure 4.
In zebrafish, V1 cells, which regulate/enable fast movement, develop into
CiAs or Circumferential Ascending interneurons (Goulding, 2009). CiAs have
several functions including motor control and sensory gating. Sensory gating is
the ability to screen for irrelevant sensory input and prevent it from interfering
with other neurological processes (Burgess and Granato, 2007). Various projects
have already been conducted with V1 cells in other organisms such as frogs and
mice. Results from tadpoles demonstrated that the cells correlating to CiAs and
V1 cells, called aINs in frogs, are implicated in swimming behaviors and sensory

11

gating (Li, et al., 2004). Similarly, V1 cells in mice are required for fast
movements. When V1 cells were ablated, mice had difficulty moving at faster
speeds although movement was still possible (Gosgnach et al., 2006). The CiA
cells in zebrafish are functionally similar to the V1 cells seen in mammals
(Higashijima, 2004), which makes them an appropriate choice for study
considering my goal of aiding in the treatment of spinal cord injuries in humans.
Each interneuron type expresses a distinct combination of transcription
factors (figure 5). Transcription factors are proteins that bind to DNA and either
promote or inhibit transcription of other genes. Therefore, understanding the roles
of

Figure 5. Each cell population in the spinal cord expresses unique transcription
factors. (A) represents the spinal cord during early development when cell
populations are still in the progenitor domains. (B) indicates spinal cord when cells
have migrated to their post-mitotic domains. The post-mitotic transcription factors
listed beside (B) are only a subset of the transcription factors expressed. Dl= dorsal
interneuron. V= ventral interneuron. MN= motoneuron. Figure kindly provided by
Dr. Lewis.

transcription factors is key to better understanding how neuronal characteristics
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are genetically specified. Several transcription factors are expressed consistently
in all vertebrate V1 cells and my research focused on a few of these, namely
Lhx1a, Lhx1b, and Lhx5 (referred to here as Lhx1a/Lhx1b/Lhx5).
A unique characteristic of Lhx transcription factors is that they are LIMhomeodomain (LIM-HD) proteins. Similar to other homeodomain proteins, the
LIM-HD transcription factors have been “well preserved throughout evolution”
(Hobert and Westphal, 2000). LIM-HD proteins are also quite similar to one
another, suggesting a shared ancestor. LIM-HD proteins can be categorized into
smaller groups based on common ancestors and the Lhx1/5 transcription factors I
study fall into the Lin-11 group (Hobert and Westphal, 2000). Found in both
vertebrates and invertebrates, LIM-HD proteins are characterized by LIM
domains, that have a
zinc-finger formation,
which

Figure 6. LIM-HD Protein Structure (Hobert and Westphal,
2000).

are

binding

protein
domains

located upstream of
the homeodomain as shown in figure 6 (Hobert and Westphal, 2000). These zinc
fingers allow the proteins to bind to other transcription factors in different
combinations and might, therefore, enable the LIM-HD proteins to help
orchestrate a variety of developmental phenomena (Hobert and Westphal, 2000).
Although other Lhx family members exist as shown in figure 7, my project
focused on Lhx1/5. Lhx1/5 are probably more closely related to one another than
to other Lhx family members because they share a more recent ancestor (Hobert
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and Westphal, 2000). Furthermore, in the zebrafish embryonic spinal cord they
are co-expressed in the same cells, suggesting that they might act redundantly
(Cerda-Moya, 2011).
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Figure 7. An evolutionary tree of the LIM-HD proteins. The red box indicates where
Lhx1/5 are located in the Lin-11 group. Other Lhx genes are located in other more
distant groups. Lhx1 and Lhx5 used to be called Lim1 and Lim5. Lhx1b used to be
called Lim6. (Hobert and Westphal, 2000).
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Experiments investigating the functions of the Lhx1/5 transcription factors
have been conducted in mouse. In these experiments, gene expression in mutant
mice lacking Lhx1 and Lhx5 was compared to WT mice in order to assess the
effects of knocking-down Lhx1/5 in the mouse spinal cord (Pillai et. a, 2007).
Pillai and colleagues found that Lhx1 and Lhx5 were co-expressed early in
neurogenesis. However, these expression patterns diverged over time (Pillai et. al,
2007). One reason for the early identical expression might be that Lhx1 and Lhx5
act redundantly initially, but then develop independent roles. In terms of their
specific functions, Lhx1/5 help to maintain inhibitory neurotransmitter fates in
mouse, but these transcription factors are not required to initially specify
inhibitory fates. Furthermore, in the absence of Lhx1/5, the cells do not adopt an
excitatory neurotransmitter identity. Additionally, Lhx1/5 are required to maintain
Pax2 expression in dorsal inhibitory interneurons, which is important because
Pax2 is also known to be required for inhibitory neurotransmitter fates (Pillai et
al., 2007; Batista and Lewis, 2008). The fact that Lhx1/5 are required to maintain
Pax2 expression suggests that Lhx1/5 are upstream of Pax2 and that both are
required to specify the inhibitory neurotransmitter fate. This shows that different
families of transcription factors interact in the specification of neurotransmitter
fates (Pillai et al., 2007).
The fact that transcription factor families might interact in interneuron
specification is relevant to my project because it means that Lhx1/5 might interact
closely with another group of transcription factors. Therefore, the absence of Lhx
could potentially impact that secondary group and vice versa. For instance, the
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phenotype of mice that lack Lhx1 and Lhx5 resembles that of mice that lack Pax2
and also that of pax2a/pax2b/pax8 triple knockdown zebrafish embryos (Pillai et
al., 2007; Batista and Lewis, 2008). Previous work in the Lewis Lab showed that
Pax2/8 are redundantly required for the glycinergic and GABAergic phenotypes
of both CiAs and other neurons that express these Pax2/8 proteins (Batista and
Lewis, 2008). Furthermore, although Pax2/8 are required to specify inhibitory
neurotransmitter fates, their absence does not result in neurons becoming
excitatory (Batista and Lewis, 2008).
Recent work by Gustavo Cerda-Moya in the Lewis Lab at University of
Cambridge, UK demonstrated that lhx1a (used to be called Lim1), lhx1b (used to
be called Lim6), and lhx5 (used to be called Lim5) are co-expressed in cells in the
zebrafish spinal cord (Cerda-Moya, 2011). As these transcription factors have
very similar sequences, this co-expression suggests that these transcription factors
might act redundantly in these cells. Therefore, it might be necessary to
knockdown all three Lhx1/5 genes in order to investigate their function.
As mentioned before, the loss of Lhx1/5 in mouse and the loss of Pax2 in
mouse or Pax2/8 in zebrafish procedures a similar spinal cord phenotype which
suggests that these transcription factors might act together to specify inhibitory
neurotransmitter fates. However, the exact details of this mechanism of
neurotransmitter fate specification are unknown. It was also unknown what the
effects of eliminating the Lhx1/5 transcription factors would be on zebrafish
embryonic spinal cord, as this had never been tested. As discussed above, Lhx
(Lim homeodomain) transcription factors are involved in the regulation of
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inhibitory neurotransmitters in the dorsal spinal cord in mice (Pillai et al., 2007).
Therefore, I predicted that they would have a similar function in zebrafish. I
hypothesized that knocking-down the functions of these transcription factors
would result in neurotransmitter deficits and potentially compromise movement
ability. Moreover, Pax2 is also thought to maintain Lhx1/5 expression in mouse,
suggesting that the Lhx1/5 and Pax2/8 might act in a reciprocal fashion to
maintain each other’s expression (Burrill et al., 1997; Cheng et al., 2005; Gross et
al., 2002; Morales and Hatten, 2006; Pillai et al., 2007; Zhao et al., 2000; Batista
and Lewis, 2008). As such, another aim of my research was to investigate the
connections between Lhx1/5 transcription factor function and Pax2a, Pax2b and
Pax8 expression.
Therefore, the main questions for my research were as follows:
1. Can we identify lhx1b mutants by genotyping? Is the lhx1b mutation
embryonic lethal?
2. What are the best reagents to test Lhx1a/1b/5 function in zebrafish?
3. What is/are the function/s of Lhx1a/1b/5 in the zebrafish spinal cord?
4. How are the Lhx and Pax families of transcription factors related? Do they
maintain one another?
.
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Materials and Methods:
The methods utilized for my research can be summarized as follows:

Figure 8. Outline of Utilized Methods.

As depicted in figure 8, I used three distinct tools to investigate the function of
the Lhx1/5transcription factors: mutant fish, RNA fusion constructs, and MOs.
Zebrafish lines
Zebrafish (D. rerio) embryos were obtained from mating crosses of wildtype (AB or TL) adults (Picker et al., 2002). Embryos were staged according to
hours post-fertilization at 28.5°C and/or morphological criteria as elucidated in
Kimmel et al. (1995). The Lewis lab was already in possession of a lhx1b mutant
allele fishline from the Sanger institute. Mutants are useful because it means that
fewer potentially toxic substances must be introduced into the embryos in order to
knock down potentially redundant genes. Morpholinos (MOs) and RNA
constructs can have nonspecific effects, meaning that they have the potential to
yield phenotypes unrelated to the gene knockdown. Furthermore, in some
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instances, the concentration necessary to fully knock down a transcription factor
might be too high to inject either individually or when combined with other
knock-down reagents. If all of the embryos die before they can be studied, then it
is impossible to understand the effects of a knock down. The lhx1b mutant was
useful because it eliminated the need to inject the lhx1b morpholino. However, the
homozygous or heterozygous mutants had to first be identified using a fin-clip
genotyping procedure.
The lhx1b mutation is a nucleotide change from a T to an A, resulting in
an amino acid change from a tyrosine (TAT) to an ochre (TAA) stop codon. As
seen in figure 9, the mutation (indicated by the highlighted “Y”) alters amino acid
110. The total sequence for this gene is 402 amino acids, meaning that the last
292 amino acids are lost when this mutation occurs. The LIM domain is
unaffected by this mutation because it consists of amino acids 3-54 (as shown in
figure 9); however, the homeodomain is lost as a result of this mutation as it
consists of amino acids 178-240. The LIM domain is responsible for binding to
proteins whereas the homeodomain binds to DNA. As such, it is possible that if a
truncated protein is produced in this mutant line it may act as a dominant negative
because it would bind partner proteins, but would be unable to bind to Lhx1/5
DNA target sites. In this way, it could titrate out WT binding partners.
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MVHCAGCERPILDRFLLSVLDRAWHAKCVQCCDCKCSLT

DRCFSREGRLYCKNDFFRRYGKCGGCAQGISPSDLVRKARSKVFHL
NCFTCIMCNKQLSTGEELYILDEYKFVCKEDYLNSNGKDTNLLSITTCSDP
SLSPESQDPQDDYKDSESGPMSDKETCNNENDEQNLGGKRRGRTTIK

AKQLETLKAAFAATPKPTRHIREQLAQETGLNMRVIQ
VWFQNRRSKERRMKQLSLGARRHMFFRSPRRMRALGDRMEPG
ELMANGHFSFYGDYQSEYYGPGSNYDYFPQGPPSQAHTPGDLGFMPSSG
PAGTPLGNMDPHHGAHHPSNDTQCFSEMISHHPGDSPSPEPSAPSIHSISTD
MCDSTPPFTSLNSLSANGYSNQLSSEMNEGTVW
Figure 9. Sequence of Lhx1b LIM and Homeodomains in a WT. The larger italicized
print indicates the amino acids of the LIM domain. The larger underlined print
indicates the amino acids of the homeodomain. The red letters indicate the beginning
of each new exon. Black lettering indicates the first exon with the subsequent blue
lettering indicating the start of the second exon, and so forth. The yellow highlighted
“Y” refers to the amino acid tyrosine and is the amino acid that is changed as a result
of this mutation.

Genotyping Lhx1b Mutant Fish
To genotype the lhx1b fish line, I cut off (“clipped”) the caudal fins of
individual fish and used them to prepare DNA. Two small glass beakers with 70%
ethanol and distilled water were prepared to sterilize the scissors and tweezers.
300 mL of 0.016% Tricaine solution diluted with water was put into a clean tank.
Fish were transferred to Tricaine solution using a net, with no more than 2-4 fish
anesthetized at one time. As soon as the fish stop swimming, they were collected
onto a plastic spoon. Using thumb and index finger, the fish was secured on the
spoon with the tail exposed over the edge of the spoon. One half to two thirds of
the caudal fin was removed using the sterilized scissors. The piece of fin was then
placed in a microcentrifuge tube containing 100 µL of the DNA extraction buffer.
DNA extraction buffer was made the day of the fin-clip. The extraction buffer
was made in a volume of 3.0 mL with 100µLof the buffer needed per fin clip. The
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3.0 mL consisted of 30µL10 mM Tris (pH 8.2), 60 µL 10 mM EDTA, 600 µL 200
mM NaCl, 75 µL 0.5% SDS, 60µL200µg/µL proteinase K, and 2175µL ddH2O.
The fish was then placed in an individual tank containing fresh fish water which
rinsed off the Tricaine solution. Fish were kept separate or in pairs of 1 male and
1 female so that they could be readily identified and correlated with their
respective DNA. Fish were kept separate until they were genotyped. These steps
were repeated until all fish had been fin-clipped. Scissors and forceps were
sterilized between fish by washing them in the aforementioned ethanol and water.
After the fin-clips, the DNA was extracted. The microcentrifuge tubes,
each containing individual fin-clipped samples in DNA extraction buffer, were
vortexed thoroughly and incubated for 2-3 hours at 55°C. Tubes were vortexed
periodically during this 2-3 hour span in order to mix contents. Proteinase K was
inactivated by incubating for 10 minutes at 100°C in a hot block. Tubes were then
centrifuged for 20 minutes at 13000 rpm at room temperature. This spun down
cell debris. The supernatant was then removed and transferred to clean, sterile
microcentrifuge tubes. The genomic DNA was precipitated by adding 200µL of
100% ice-cold RNAse-free EtOH. Tubes were mixed or briefly centrifuged and
then placed at -20°C for at least 1 hour. Genomic DNA was then precipitated by
centrifuging for 20 minutes at 13000 rpm at 4°C. Next, ethanol supernatant was
carefully removed and the pellet was washed with 500µL of fresh 70% EtOH.
Tubes were centrifuged for an additional 3 minutes at 13000 rpm at 4°C and
supernatant was again removed. The resulting pellets were air-dried for 5 minutes
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at room temperature before being re-suspended in 100µL of H2O. The resuspended DNA was then stored at -20°C.
Forward primer: GCGAAGAACTGTACATCCTAGATGAATT
Reverse primer: TTGGCGGGTCTTTATGAAAATATATGAC
For PCR the following reactions were assembled:
[Stock]

[Final]

Nuclease-free H2O

5.351 µl

NEB Thermo Pol Reaction Buffer 10x

dNTPs

Volume

10 mM each

1x
209 µM

NEB Taq polymerase

1.0 µl
0.209 µl
0.04 µl

Forward primer

10 µM

0.2 µM

0.2 µl

Reverse primer

10 µM

0.2 µM

0.2 µl

Genomic DNA

variable

variable

3.0 µl

Total Volume

10 µl

The samples were subjected to the following PCR conditions:
94°C 180 sec

92°C 20 sec
65°C 30 sec

18 cycles

72°C 60 sec

92°C 20 sec
56°C 30 sec
72°C 60 sec

15 cycles
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72°C 180 sec
16.0oC held until samples removed

Following the PCR, a digest reaction was performed. The following digest
reaction was assembled in a 20µL volume: 5.875µL Nuclease-free water, 2.0µL
NEBuffer 4, 2.0µL Acetylated BSA, 0.125µL DraI, 10.0µL PCR reaction
product. The reaction was incubated for 2 hours at 37°. While the digests were
incubating, a 2.5% TBE agarose gel was prepared. 4µL DNA loading dye was
added to each of the digest reactions (giving a total volume of 24 ul). Then 1015µL of each sample was loaded into a different individual well on a 2.0% TBE
agarose gel. The gel was run at 130 volts for 40 minutes. This was a change from
the usual protocol because I found that running a TBE gel for a long period of
time at a slower voltage resulted in a clearer demarcation of DNA sizes.
Injections into zebrafish embryos
A Sutter Instrument Company glass-puller (model P-2000; program #8)
and glass capillary tubes (10 cm length, O.D 1.2 mm, I.D. 0.94 mm) were used to
make the injection needles. Injection plates were made using a specific mold that
creates grooves in a 1% agarose gel in which the embryos rest. The plates
themselves were made in standard 100 mm petri dishes using 1% agarose in
embryo medium. 3L of a 60x stock solution of embryo medium requires 51.6g
5mM NaCl, 2.3g 0.17mM KCl, 8.7g 0.33 CaCl2.2H2O, and 14.7g 0.33 mM
MgSO4.7H2O. Next, embryo medium is buffered to pH 7.8 with hepes (1g for
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approximately 100 mL of 60x stock solution). Then 166
mLs of 60x stock solution with hepes is diluted with 20
mL 0.01% Methylene Blue in dH2O to make 10L. Molds
did not touch the base of the petri dish, but were deep
enough so that embryos were not touching the surface of
the liquid as seen in figure 10. Once the agarose set, the
molds were removed using forceps and the
Figure 10. Injection mold set up. Based

dishes were filled with embryo medium to on figure by Dr. Lewis.
keep them moist. Adult fish were set up the night before in tanks with dividers
separating males from females to ensure that the embryos were laid only once
everything was set up for the experiment.
The morning of injections, a needle holder jar containing a small amount
of distilled water in the bottom (to stop the needles from drying out) was used to
hold

loaded

needles. Needles
were

loaded

using a P2 or
P20 pipette and
filtered

Figure 11. Injection of 1-cell embryo. Kindly
provided by Dr. Lewis.

tips.

Phenol red was mixed with the
MOs or RNA so that injected

liquid was visible in the embryo. If injection plates were made the night before,

25

they were warmed to room temperature so as not to temperature shock the
embryos. Once laid, embryos were collected from tanks and transferred to
injection plates using plastic or glass pipettes. Forceps were used to guide
embryos into the appropriate grooves in the plates. A General Valve Corporation
picospritzer model II was used for the injections. Needles were secured into the
picospritzer which forced compressed air down the capillary tube and controlled
how much of the injected material was released. As illustrated in figure 11, 1-cell
stage embryos were injected in the yolk region of the embryo. After injecting,
embryos were inspected to ascertain that none were visibly harmed during
injections. Damaged embryos were removed. Embryos were placed into a 28.5°C
incubator. Wild-type uninjected controls were maintained for each pair of fish that
laid embryos.
Several hours later, injected embryos were inspected. If phenol red
remained in the yolk, these embryos were separated or discarded as the injected
material had not fully permeated the embryo. Infertile embryos were also
removed at this stage. The rest of the embryos were removed from the injection
plates and pipetted into clean petri dishes with fresh embryo medium. These
dishes were then placed back in the 28.5°C incubator overnight. Embryos were
fixed at 24-27 hours depending on the nature of the experiment. Staging was
performed based on a staging chart, pigmentation, and somite numbers. Embryos
were fixed in 4% paraformaldehyde in phosphate-saline buffer (PBS) and put
overnight at 4.0°C.
RNA fusion construct injections
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RNA fusion constructs were injected in order to determine the function of

Figure 12. Diagram of RNA Constructs and protein domains that they encode for. The
first 738 nucleotides of the lhx5 sequence were used. The yellow box represents the
first exon (494 nucleotides) in the lhx5 sequence. The blue box represents the second
exon (224 nucleotides) in the lhx5 sequence. The orange box is the portion of the third
exon (20 nucleotides) that was included from the lhx5 sequence. The green box
represents where the EGFP,Vp16, or EnR sequence was attached. The first LIM domain
is encoded by nucleotides 3-61 and the second LIM domain is encoded by nucleotides
62-125, both fall within exon 1. The homeobox domain is encoded by nucleotides 180239 and falls within exon 2.

the Lhx1/5transcription factors. Four different RNA constructs were injected:
Lhx5VP16, Lhx5GFP, Lhx5EnR (Lewis Lab), and Lhx5EnR (Westerfield Lab).
Each of these constructs contained the first 738 nucleotides of the Lhx5 sequence
which includes 2 LIM domains and the homeobox (figure 12). Additionally, these
constructs each had either a Vp16, a GFP, or a EnR sequence attached after the
Lhx5 coding sequence (figure 12). The Lhx5VP16 was expected to be a dominant
active version of the desired protein while Lhx5EnR was hypothesized to be a
dominant negative version of the desired protein based on research using a
Lhx5EnR construct in the Westerfield lab (Peng and Westerfield, 2006). In order
to prepare the RNA, plasmid DNA was linearized with SacII. The reaction was
assembled in a 20µLvolume consisting of 2µLrestriction enzyme, 1 ug of DNA,
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0.5µLrestriction enzyme buffer, and the rest was dH2O. The reaction was placed
at 37°C for 2 hours. DNA was run on a 1% TAE gel to make sure it was cut. If
cut,1µL of proteinase K was added and the reaction was placed at 37°C for 30
minutes. DNA was then extracted using phenol/chloroform and chloroform.
Finally, DNA was precipitated by adding 1µL glycogen (as an inert carrier), 1/10
volume of 4M NaCl, and 2x volume of EtOH and placing at -20°C overnight.
After spinning the reaction at 13,500 rpm, the supernatant was removed and the
pellet was washed with 80% cold EtOH. Then the DNA was re-suspended in
14µLdH2O. RNA was then made using an sp6 Ambion mMessage mMachine kit.
Splice-Blocking Morpholino injections and controls
Morpholinos (MOs) are antisense oligonucleotides that interfere with
RNA transcription to protein or RNA splicing. Although they are synthetic
molecules, MOs mimic the design of actual nucleic acids and bind to the usual
complementary sequences (Gene Tools). Both
types of MOs, ATG and splice-blocking (S-B)
MOs,

were

utilized.

oligonucleotides

that

ATG
bind

to

MOs

are

the

5’-

untranslated region of mRNA and therefore
interfere with movement of the ribosomal
initiation complex. The initiation complex

never

reaches

the

start

codon

and

consequently translation can never take place.

Figure 13. Schematic of how ATG
MOs work. Figure kindly provided
by Dr. Lewis.

28

Because translation never occurs and the protein is absent (or reduced) as
demonstrated in figure 13, we can determine the function of the unmade protein
(Gene Tools). Splice-blocking MOs prohibit the removal of introns so that the
translated product no longer codes for the same protein (Gene Tools). Spliceblocking MOs were primarily used because the effectiveness of these MOs can be
checked by reverse transcription polymerase chain reaction (RT-PCR) to check if
the RNA has been correctly spliced. Generally speaking, by inhibiting or reducing
protein production, MOs enable us to determine the function that each gene is
necessary or required for.
MOs were injected into 1-2 cell stage embryos from a cross of wild-type
AB fish. The original ATG and S-B MOs had been used in a pilot experiment in a
previous Lewis lab study. Another MO was used successfully in Peng and
Westerfield (2006). Sequences (Cerda-Moya, 2011) were as follows:
Lewis lhx1a S-B: TGCAAGCTGTAACTGAATAGGGAAA
Lewis lhx1a ATG: AGCCCGCACAGTGGACCATCGTCTT
Lewis lhx1b S-B: TGCAGGTGGTAACTGTAAAAAAGCA
Lewis lhx1b ATG: TCTCGCATCCAGCACAGTGGACCAT
Lewis lhx5 S-B: CGACACTGTGGTATGATAAAGAACC
Lewis lhx5 ATG: TGCACCATCATTCCGCCCTGGAGGG
Peng and Westerfield lhx5: GTGCGTTGTTCTCACCTGAATCACC.
Lewis ATG MOs were injected at 2.1µg/µL, 3.02µg/µL and 3.32µg/µL.
These concentrations were chosen based on previous work in the Lewis lab. p53
MO was also injected in a mix with the other MOs at 4.0µg/µL to inhibit any
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nonspecific apoptosis effects. p53 reduces the possibility that the phenotypes
observed in the MO injections are the result of non-specific toxicity or apoptosis
(Robu et al., 2007). Lewis S-B MOs were originally injected at 1µg/µL and
2µg/µL each. It appeared that there was an effect with these concentrations only
on Lhx5 splicing (see results section). However, Lhx1a and Lhx1b splicing did
not seem affected by these concentrations. Concentrations of all three MOs were
increased
times

Figure 14. RT-PCR Protocol Illustrated. Figure based on
Qiagen One-Step RT-PCR Kit.

several

to

2.5µg/µL,

3.0µg/µL,

3.5µg/µL,

and

4.5µg/µL.

visible

No

knock-down

of RNA splicing was apparent at any of these concentrations by PCR assay.
Although Lhx5 had originally shown an effect at the 1 µg/µL and 2 µg/µL
concentrations, it was later shown via RT-PCR that this result was anomalous (see
results).
To examine whether the absence of a knock-down was the result of an
ineffective MO, a second lhx5 MO was injected that had been used successfully
by Peng and Westerfield (2006). Based on the concentrations suggested by Peng
and Westerfield (2006), the new lhx5 MO was injected originally at 4.0µg/µL,
5.0µg/µL, and 6.0µg/µL. The concentrations were subsequently increased to
6.5µg/µL, 7.5µg/µL, and 8.3 µg/µL. In this case, there appeared to be an effect on
RNA splicing (see results).
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Wild-type embryos obtained from each pair of zebrafish that laid were
compared to injected embryos from that same pair to ensure that morphological
changes were in fact the result of injections. Furthermore, these control embryos
were also used in the subsequent RT-PCR experiments to maintain a precise
control throughout.

RT-PCR
After injecting splice-blocking MOs, I performed a reverse transcription
polymerase chain reaction (RT-PCR). RT-PCR was utilized to see if the spliceblocking MOs had fully blocked RNA splicing. To prepare for the RT-PCR, 25
injected embryos were collected per tube. All of the liquid (embryo medium) was
removed and the RNA was extracted using 250µLAmbion TRI Reagent®. Next,
the procedures for homogenization, RNA extraction, RNA precipitation and wash,
and RNA solubilization were performed according to the protocol listed in the
Qiagen One-Step RT-PCR kit (figure 14). RNA was re-suspended in 20µLof
water. 2.4µLof DNAase Buffer (RNase-free DNase) and 2µLof DNase were
added and the reaction was incubated for 15 minutes at 37°C and then for 10
minutes at 65°C. 0.5µL RNAsin was then added and the RNA was stored at 20°C.
The RT-PCR procedure and reagent volumes were performed according to
the Qiagen OneStep RT-PCR kit. Primers used were as follows:
lhx1a rtpcr SB2-3FW TGATGTGTAACAAGCAGCTTTC
lhx1a rtpcr SB2-3RV AATAACTCGCATGTTGAGTCC
PCR product= spliced 395bp versus un-spliced 985bp
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lhx1b rtpcr SB2-3FW ACGTTATGGCACTAAATGTGG
lhx1b rtpcr SB2-3RV CTGCTTGGCTTTGATTGTAGT
PCR product= spliced 397bp versus un-spliced 691bp
lhx5 rtpcr SB2-3FW GTTTCATCTCAACTGTTTCACG
lhx5 rtpcr SB2-3RV ATGTTAAGGCCTGTCTCCTG
PCR product= spliced 411bp versus un-spliced 3010bp
The following program was set up on the PCR machine:
30min 50°C
15min 95°C
35X [30sec 94°C
45sec 57°C
60sec 72°C]
10min 72°C
Samples were then run on a 2% TBE agarose gel at 120 volts for 40 minutes.

in situ
in situ hybridization was performed as described in Concordet et al.
(1996). To determine neurotransmitter phenotypes, I focused on genes
corresponding to proteins which transfer or produce specific neurotransmitters
(Batista and Lewis, 2008; Higashijima, 2004). I used the following probes: glyt2a,
glyt2b, and pax2.1. glyt2a and glyt2b were used to test whether the knock-down
of Lhx5 resulted in a change in neurotransmitter fate in these cells. glyt2a and
glyt2b are markers of glycinergic cells which would enable me to see whether the
CiAs retained their inhibitory neurotransmitter fate in the absence of Lhx. pax2.1
was used because of previous work conducted in mice which suggested a
relationship between the Lhx and Pax families of transcription factors (Pillai, ). I
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also decided to use pax2.1 because it was one of my probes that had worked the
best in previous in situ experiments.

33

Results
Genotyping lhx1b Mutants
Developing a method to identify lhx1b mutants was important to my
project because it not only was more cost effective and time efficient than sending
fish to sequencing, but also eliminated the number of constructs I had to inject in
order to knock-down all three Lhx1/5 genes. After examining the sequence of the
mutation, I determined that there was no restriction enzyme site created or
removed by the mutation; however, by creating PCR primers that amplified the
region around the mutation and altered one nucleotide, I was able to introduce a
restriction enzyme site so that an enzyme would cut in the WT but not in the
mutant DNA. Creating a primer that did not end on a “T” nucleotide was
important because it would have been less stringent. Furthermore, I did not want
the last nucleotide to be the one that changed. The enzymes DraI and PsiI both
had the potential for introducing their cutting site into the WT DNA. Both PCR
primers that introduced a nucleotide change were designed to be 28 base pairs in
length. The G/C ratio and melting and annealing temperature were also
comparable between both. Therefore, I tested both options. By introducing a
restriction enzyme site, I eliminated the need to send the DNA from the PCR to be
sequenced. Instead, I could do a restriction enzyme digest on PCR products and
run the DNA on a gel. This method is much cheaper and faster than sending the
DNA to sequence from each lhx1b mutant fish.
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Table 1. Primer sequences (compared to wild-type) used to identify Lhx1b
mutants.
Name

Sequence

Wildtype

GGCGAAGAACTGTACATCCTAGATGAATATAAATTTGTCTGCAAG
GAGGATACTTGAATAACAGCAATGGAAAAGACACAAACCTTCTGT
CAAgtaagtcggtgattttgggccttgtgggcctacatgagataaaatatttacattagacactgaggatacaa
tcaagagtattagtttttcccatctccgtgttcgttaactgcaggcaattggcgggtctttatgaaaatatatgac

PsiI

GGCGAAGAACTGTACATCCTAGATGATTATAAATTTGTCTGCAAG
GAGGATTACTTGAATAACAGCAATGGAAAAGACACAAACCTTCTG
TCAAgtaagtcggtgattttgggccttgtgggcctacatgagataaaatatttacattagacacatgaggatac
aatcaagagtattagtttttcccatctccgtgttcgttaactgcaggcaattggcgggtctttatgaaaatatatgac
actatttattaaaatgtattagtgatacaaaatgcgttgtctgtgtagaatggcattgcatttcgatagacaataggc
ctacatgataatttacgcatgatatttaagtggcctacataacagcttctaaatgtgcttttttacag

DraI

GGCGAAGAACTGTACATCCTAGATGAATTTAAATTTGTCTGCAAG
GAGGATTACTTGAATAACAGCAATGGAAAAGACACAAACCTTCTG
TCAAgtaagtcggtgattttgggccttgtgggcctacatgagataaaatatttacattagacacatgaggatac
aatcaagagtattagtttttcccatctccgtgttcgttaactgcaggcaattggcgggtctttatgaaaatatatgac
actatttattaaaatgtattagtgatacaaaatgcgttgtctgtgtagaatggcattgcatttcgatagacaataggc
ctacatgataatttacgcatgatatttaagtggcctacataacagcttctaaatgtgcttttttacag

Reverse gtaagtcggtgattttgggccttgtgggcctacatgagataaaatatttacattagacacatgaggatacaatcaa
primer
gagtattagtttttcccatctccgtgttcgttaactgcaggcaattggcgggtctttatgaaaatatatgacactattt
sequence attaaaatgtattagtgatacaaaatgcgttgtctgtgtagaatggcattgcatttcgatagacaataggcctacat
gataatttacgcatgatatttaagtggcctacataacagcttctaaatgtgcttttttacag
* Primer sequence is underlined. Red indicates mutation site. Italics indicates
nucleotide change site. WT=T; mutant=A. Fragment should be 241 bp.
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All primers were custom DNA oligos from Integrated DNA Technologies.

In order to see which 5’ primer was more effective at introducing a restriction
enzyme

site,

both

possible

combinations of primers were tested
on wild-type genomic DNA. The
enzymes were tested on wild-type
genomic DNA because the restriction

Figure 15. Demonstrating the effectiveness
of PsiI vs. DraI.

enzyme site introduced meant that the
enzyme would cut in the wild-type

and not in the mutant. DraI was determined to be the better enzyme because the
differences between the cut and uncut DNA on an agarose electrophoresis gel,
while subtle, were more apparent than the DNA cut with PsiI. Based on the results
from wild-type tests, it was determined that DraI was the better enzyme to
identify the lhx1b mutants (figure 15). The experiment was then repeated using
DraI and the fin-clipped DNA. Initially, 4 genotyped fish were also sent to
sequencing at Cornell University to confirm that the method could correctly
identify heterozygous and homozygous mutants.
As discussed in the materials and methods section, I designed a protocol to
identify lhx1b mutants. This PCR-based genotyping procedure that used specially
designed primers that introduced a restriction enzyme site into WT, but not
mutant DNA, was successful in identifying lhx1b mutants. Known wild-type fish
were used as a control to ascertain that the procedure was working. The shorter
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band is the cut WT DNA (you do not see the second fragment because it is too
small). The longer band is the uncut mutant DNA. On the gel, two bands

Figure 16. Results of Lhx1b Genotyping. Two bands (both the long and the short)
correspond to heterozygous fish (lane 1, 4, & 9). Lanes appearing like lane 2 were
WT, as they only had the shorter or weaker band. This could be because of an
incomplete digest. In this case, it is safer to assume they are WT as opposed to
heterozygous. Lanes with only the longer band (land 7) were homozygous.

corresponds to a heterozygous fish (figure 16). Heterozygous fish yield two bands
because one band corresponds to the uncut mutant DNA (the longer one) and the
second band corresponds to the cut WT DNA band (the shorter one). The protocol
resulted in clearly distinguishable bands of two different sizes on the gel. This
protocol was successful because the mutant and WT fish could be differentiated
from one another, which was confirmed by sequencing.
In total, 6/22 fish (27.3%) were WT, 3/22 fish (13.6%) were homozygous
for the Lhx1b mutation, and 13/22 fish (59.1%) were heterozygous for the
mutation. This is approximately what was expected because of Mendelian
genetics where ¼ should be homozygous, ¼ should be wild-type, and ½ should be
heterozygous. A chi squared test equals 1.545 with 2 degrees of freedom which
gives a p value of 0.4618. The two-tailed P value for this data indicates that the
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difference between the observed and expected percentages of WT/het/hom fish is
not statistically significant.
Obtaining a lhx1b homozygous mutant fish was unexpected as fish sent by
the Sanger Institute are usually the progeny of an outcross. As explained by
Mendelian genetics, it is impossible to obtain a homozygous mutant from an
outcross of fish. Therefore, to be sure that the protocol really yielded a
homozygous mutant, I confirmed the findings from this genotyping procedure by
sequencing 4 fish at Cornell University (results in figure 16). At first, we were
concerned that the band on the gel indicating a homozygous mutant could have
been
the

because
restriction

enzyme did not
cut properly. If
Figure 17. Sequencing results for 3 separate fish.

this was the case, the absence of the shorter band on the gel may have been an
experimental error as opposed to an indication that the fish was a homozygous
mutant. The WT sequencing picture (seen farthest left in figure 17) shows
residues corresponding to only the A nucleotide as indicated by the red arrow.
This was what I expected given that a WT fish should be homozygous for the WT
allele. The homozygous (hom) fish sequencing indicates a T nucleotide in this
position, consistent with a homozygous mutation. Finally, the heterozygous fish
has both the homozygous and wild-type nucleotide (both A and T). The
differences between the sequences for the WT, homozygous mutant, and
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heterozygous mutant demonstrate that these fish were indeed heterozygous and
homozygous lhx1b mutants.
Identifying a homozygous mutant adult fish was a major result because it
shows that the mutant is homozygous viable. Prior to my work, it was unknown
whether a lhx1b homozygous mutant fish would be viable. Initially, we were
concerned that perhaps this mutation did kill some of the fish because the number
of identified homozygous mutants was lower than the expected number (13.6%
rather than 25.0%). However, a chi square test comparing homozygous mutants to
the rest of genotyped fish equals 1.515 with 1 degree of freedom which gives a p
value of 0.2184. The two-tailed P value for this data indicates that the difference
between the observed and expected percentages of mutants versus nonhomozygous-mutant siblings is not statistically significant. Moreover, the chi
square test comparing all mutants (both heterozygous and homozygous) and wildtype fish equals 0.061 with 1 degree of freedom which gives a p value of 0.8055
which is not statistically significant so this low frequency of homozygous mutants
could be due to chance. To test this, I would need to identify more fish and
increase the numbers. This p value indicates that the difference between the
observed and expected percentages of homozygous and heterozygous mutants
versus wild-type is not statistically significant. Based on this data, it does not
seem that homozygous mutants preferentially die. However, they might
preferentially die, but I would need a larger sample size to see if the difference
between the observed and expected numbers of lhx1b homozygous mutant fish
becomes statistically significant. It is possible that this mutation is not
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homozygous viable in all individuals perhaps because the mutation automatically
triggers the DNA for degradation or because the mutation eliminates the
homeodomain which is lethal to the embryos.
RNA injection results
Three constructs were initially injected: Lhx5Vp16, Lhx5GFP, and
Lhx5EnR. Each of these constructs was injected several times as described in

Figure 18. Phenotypic effects of Lhx5EnR RNA Injections. In (A and B) red boxes indicate
morphological differences in the eyes. In (C and D), red arrows indicate misshapen tails and
somites.

table 2 at different concentrations with the hopes of optimizing the results. As
mentioned in materials and methods, I expected Lhx5EnR to act as a dominant
active construct, Lhx5Vp16 to act as a dominant negative construct, and
Lhx5GFP to show the endogenous expression pattern (Peng and Westerfield,
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2006). Furthermore, since the DNA binding domains for Lhx1a, Lhx1b, and Lhx5
are similar, I expected that these RNA construct might interfere with the activity
of all three of these transcription factors. The major advantage of RNA constructs
was that we thought they might affect all three Lhx activities so we could
potentially knock down all transcription factors using just one reagent. During
these experiments, I noticed several significant morphological phenotypic
changes (figure 18).

In the injected embryos, the eyes were clearly less

pronounced and not well defined. Furthermore, the midbrain/hindbrain boundary
was not clearly differentiated. Moreover, the somites in the spinal cord of the
embryo appeared less distinct. Finally, the tail of the embryo was more rounded
and not as well defined as in the wild-type, un-injected embryos. All of these
phenotypes were in comparison to a wild-type, un-injected control obtained from
the same pair of zebrafish that laid the injected embryos. Table 2 below indicates
the abnormalities seen in the injected embryos as compared to the wild-type
controls. Each of the constructs appeared to result in similar morphological
phenotypes.
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Table 2. Injection results with the original RNA fusion constructs.
Construct
Injected

Concentration
& volume

Lhx5EnR

8.42µg/µL;
3-4 nL

Lewis

Lhx5EnR
Lewis

Lhx5EnR
Lewis

Number

Total
Dead

Phenotype

Control

70

58.5
%
(41)

23 had misshapen bodies,
distorted somites, and
misshapen
head
structures. 5 were WT
looking.

1 dead; 1 with
just head and
yolk;
rest
look WT

8.42µg/µL;
3 nL

54

48.1
%
(26)

17 had misshapen heads,
bodies, and tails. Some
tails had kink. Some tails
were short and stubby.
One
embryo
was
cyclopic.

8
infertile;
some
had
small
chorions

8.42µg/µL;
4 nL

75

20.0
%
(15)

9 were misshapen and 15 infertile
distorted. 3-4 were WT,
though 2 had weird eyes. N= 20
Many had small chorions,
mushed heads, stubby
trunks, and missing eyes.
Some embryos had just a
tail

Injected

*short body phenotype
Lhx5EnR
Lewis

Lhx5Vp16

21.4µg/µL;
3nL

3.22µg/µL;
2-3 nL

30

70

43.3
%
(13)

38.5
%
(27)

8
were
misshapen,
distorted, and mostly
yolk. 3 were very
misshapen
with
malformed heads. 1 had a
larger head and no
distinct eyes.

3
infertile;
otherwise
look WT

20 were misshapen and
distorted.
8
had
malformed trunks and/or
heads. 1 was very thin.
Some embryos exhibited
trunks that appeared to
zigzag.

1 dead;
mush;
deformed

N= 20

N= 20

1
1
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Lhx5Vp16

Lhx5Vp16

3.22µg/µL;
2-3 nL

3.22µg/µL;
3-4 nL

50

38%
(19)

45

57.8
%
(26)

Lhx5Vp16

3.22µg/µL;
2-3 nL

50

54.0
%
(27)

Lhx5Vp16

8.17µg/µL;
4-5 nL

55

65.5
%

Lhx5GFP

3.94µg/µL;
3-5 nL

50

42.0
%

3.94µg/µL;
4 nL

107

4
infertile;
otherwise
look WT
N= 20

12 were misshapen and WT looking
distorted and mostly yolk.
1 was very small with a N= 20
narrow body. 3 were
mush. 3 were WT (but
two moving significantly
less so). 1 had a curly tail.
2 had weird eyes or were
cyclopic.
18 were misshapen and WT looking
distorted and mostly yolk.
1 was very misshapen and N= 20
disturbed. 6 were WT
looking.

11 were misshapen and/or WT looking
distorted and mostly yolk.
8 were funny with some N=20
(36) being very disturbed.
Others had just unusual
body parts. 1 had very
strange boxy tail and odd
somites.
Finally,
1
appeared WT.

(21)

Lhx5GFP

15
were
misshapen,
distorted, and mostly
yolk. 5 were misshapen
with malformed heads,
stubby tails, and no
distinct eyes. 1 appeared
WT.

7.5
%
(8)

Many had misshapen
heads
and
exhibited
necrosis. Some had no
defined heads, stubby
tails, and misshapen eyes.

9 died (after
removing
infertiles). 3
mush; 1 with
funny
head
N= 20

Some had weird heads. 9 with small
The tails were also either yolks.
absent or kinked/stubby.
N= 20
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Lhx5GFP

3.94µg/µL;
3 nL

56

25.0
%
(14)

6 were misshapen, but WT looking
many were WT looking.
N=20

Lhx5GFP

3.94µg/µL;
3 nL

76

7.9
%
(6)

17 had funny heads and 1mush; rest
several
with
smaller WT looking
bodies and stubby tails.
N=20

After working with these RNA constructs, I discovered that the wrong
enzyme for linearizing the template DNA, BssHI, had been entered into the

Figure 19. Plasmid map for Lhx5EnR. Red box indicates the sp6 RNA polymerase start
location. The yellow box indicates approximately where a BssHII site exists within the
Lhx5 sequence. As shown in the picture, the distance between the sp6 start location and
the BssHII cut site is shorter than the full length of the insert and does not include the end
of the Lhx5 coding sequence or the EnR sequence. The blue box indicates where the new
enzyme I used, SacII, cuts.

database by a previous student. Consequently, the RNA injected into the embryos
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did not correspond to the intended RNA fusion constructs. All three RNA
constructs that I initially used were made as a BamHI-Lhx5-EcoRIEGFP/EnR/Vp16-Xhol cassette cloned into pCS2+. Only the first 738 nucleotides
of the Lhx5 coding sequence were used which is equivalent to the first 246 amino
acids. These 246 amino acids contain two LIM binding domains which are amino
acids 3-61 and amino acids 62-125. The LIM homeobox is also included in these
246 amino acids and is amino acids 180-239. Unfortunately, the BssHII site is
present in the Lhx5 sequence used (figure 19). The BssHII site occurs at
nucleotides 238-243 of the Lhx5 coding sequence meaning that the last 495
nucleotides of the Lhx5 sequence in the construct as well as the EGFP/EnR/Vp16
portions are excised when BssHII is used (figure 19). Therefore, when I was
making sense RNA to inject, I only was only transcribing nucleotides 1-243. This
means that I was only including the first LIM binding domain and was not
including the second LIM domain or the LIM homeobox. As such, the resulting
RNA I made could have been unstable because it did not include a stop codon or a
PolyA tail in addition to missing the other aforementioned portions. Although it
may also have acted as a dominant negative, as the remaining LIM domain may
have still been able to bind to partner proteins.
After discovering this mistake, I relinearized the DNA with the correct
enzyme, which is SacII. However, after linearizing with this enzyme and injecting
RNA made from these newly cut template DNAs, only wild-type-looking
embryos were seen, suggesting either that there was a problem with the initial
DNA preparation, or that the correct construct does not produce morphological
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phenotypes. In order to distinguish between these possibilities, I performed a new
midi-prep as per the Qiagen kit instructions from a glycerol stock to obtain a fresh
DNA preparation.
Following the midi-prep, I remade and injected the RNA. My initial round
of injections yielded an apparent phenotype in that the embryos were distorted
with misshapen heads and bodies. However, my second injection round with this
new RNA yielded different results (table 3). The third time I repeated the
experiment the results were the same as in round two, suggesting that either there
was no effect or that the effect had no visible morphological phenotype.
Table 3. New RNA injection results.
Injection
Round
#1

#2

#3

RNA
Number Number Comments/Phenotypes Control
concentration
and volume injected dead
injected
189.9ng/µL
40
40.0%
17 all yolk/mush; 7
3nL injected
(16)
unable
to
be infertile;
dechorionated;
7 WT
infertile
looking
N= 20
189.9ng/µL
45
0.0%
10 were necrotic, 15 2
3nL injected
(0)
WT-looking
infertile;
WT
looking
N=20
189.9ng/µL
70
2.85%
WT-looking
WT
3nL injected
(2)
looking;
N=20

Using ATG Morpholinos to knock-down Lhx1a/1b/5 function
Initially the ATG MOs were injected at two concentrations. Mix#1
consisted of 2.1µg/µL each of Lhx1a, Lhx1b, and Lhx5 as well as 4.5µg/µL of
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p53 MOs. Mix#2 consisted of 3.32µg/µL each of Lhx1a, Lhx1b, Lhx5 and
3.84µg/µL p53 MO. In the initial injection round, mix #1 was not concentrated
enough to yield an effect while mix #2 was too toxic to the embryos. In mix #2:
the embryos were either dead or too sick to use in an in situ. However, when the
concentration of each of the lhx1a, lhx1b, and lhx5 MOs was reduced to
3.02µg/µL and the p53 MO was kept at 3.84µg/µL, the ATG MOs produced
seemingly promising results in that the embryos survived and showed a
morphological phenotype. As mentioned above, p53 MO was also added to the
MO mix in the case of the ATG MO injections. Embryos injected with p53 as part
of the ATG MO mixture did not appear morphologically different from those
injected with MO in the absence of p53.
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Table 4. ATG Morpholino Results.
What

Concentration Mush

injected

Injected

MO Mix#1

Lhx1a, Lhx1b, 1.92%
Lhx5
@ (1)
2.1µg/µL each
and p53 @ 4.0
µg/µL (~2nL)

MO Mix#1

MO Mix#2

Dead

Funny/

WT-

Total Control

Misshapen

like

3.84%
(2)

46.2%
(24)

48.1.%
(25)

52

WT
looking;
N= 20

Lhx1a, Lhx1b, 2.63%
Lhx5
@ (1)
2.1µg/µL each
and p53 @ 4.0
µg/µL (~4 nL)

0.0%
(0)

47.4%
(18)

50.0%
(19)

38

WT
looking;
N=20

Lhx1a, Lhx1b, 75.6%
Lhx5
@ (34)
3.32µg/µL
each and p53
@ 3.84 µg/µL
(~3nL)

15.6%
(7)

8.9%
(4)

0.0%
(0)

45

WT
looking;
N=20

Middle
Lhx1a, Lhx1b, 13.1%
Concentration Lhx5
@ (14)
3.02µg/µL
each and p53
@ 3.84 µg/µL
(~2nL)

19.6%
(21)

67.3%
(72)

0.0%
(0)

107

WT
looking;
N=20

Middle
Lhx1a, Lhx1b, 27.5%
Concentration Lhx5
@ (11)
3.02µg/µL
each and p53
@ 3.84 µg/µL
(~4nL)

22.5%
(9)

50.0%
(20)

0.0%
(0)

40

WT
looking;
N=20
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Determining whether splice-blocking MOs completely eliminate RNA splicing
Initially S-B MOs were injected at 1.0µg/µL and 2.0µg/µL. The initial
concentrations were chosen based on injections conducted previously in the Lewis
lab with the same constructs. I injected the S-B MOs into 1-4 cell stage embryos,
incubated them until they were ~24 hpf, removed their chorions, and put them in
TRI Reagent®. Next, I followed the RT-PCR protocol detailed in the materials
and methods section and depicted in figure 13. After extracting the RNA, I
performed an RT-PCR reaction using specific primer sets. The primers were also
used on WT cDNA to test that they were working. Furthermore, for each sample,
two different sets of primers were used: the correct primer set to test for the
blocking of RNA splicing and a second primer set to test that the RNA was
viable. For example, if I injected lhx5 S-B MO I extracted the RNA from this
sample and ran an RT-PCR with two tubes of this sample. In one of the tubes, I
used lhx5 primers and in the other I used either lhx1a or lhx1b primers. If the
RNA was viable, the lhx1a or lhx1b primers should always yield a band because
that transcription factor gene should have been unaffected by the injections. By
testing the primers in this way, I was checking that the template RNA was viable.
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The initial results shown in figure 20 indicate that the embryos injected

Figure 20. RT-PCR #1 Lewis S-B MOs. Each lane is labeled with the S-B MO injected and
the primers used. Example: lane 2 is lhx1b primers on WT DNA. Lanes 1-3 were run to
check that primers were working as this was the first time they had been used. Lanes
5, 7, 9, 11, 13, and 15 are controls for lanes 4, 6, 8, 10, 12, 14, respectively.

with1µg/µL of lhx1b S-B MOs did not produce a band with the lhx1b primers.
The absence of a band could suggest that splicing has been blocked and the RNA
is unstable. However, an alternative possibility is that the cDNA synthesis did not
work possibly due to contamination with RNases during the RNA prep or cDNA
synthesis. Both samples injected with 1µg/µL of lhx1b demonstrated similar
problems as neither the control nor the experimental showed up on the gel. This
suggests that the lack of bands was indeed due to a problem in the cDNA
synthesis. In samples from embryos injected with 2µg/µL of lhx1a and lhx1b MOs
there was also no significant blocking of RNA splicing. However, this conclusion
was made only by comparing the bands from samples of differing concentrations
to one another because in these cases the controls did not show up on the gel. This
may be due to the PCR conditions used. Finally, the samples from embryos
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injected with 1µg/µL and 2µg/µL of lhx5 MO suggested that the RNA from this
gene might not be being completely spliced. This was because when the lhx1a
primers were used on both samples, the bands were clear which indicated that the
cDNA synthesis had worked and the primers were working. However, in
comparison, the lhx5 primers yielded weaker bands, with the 2µg/µL band
appearing weaker than the 1µg/µL band. This trend suggested that as the
concentration was increased the splice blocking became more severe.
The same injection concentrations were repeated for Lhx5 to confirm the

Figure 21. RT-PCR for injection round two with Lewis S-B MOs. Each lane is marked with the
primers that were used and which sample type they were used on. For example, lane 2 is
lhx1a primers on lhx1a S-B MO cDNA. Lanes 1, 6, and 11 are genomic controls for lhx1a,
lhx1b, and lhx5, respectively. Genomic samples did not show up for lhx1a or lhx5 (lanes 1
and 11). This may be due to the PCR conditions used.

blocking of splicing. The concentrations injected were also increased for all genes
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because I had not seen a complete knock-down in any case (figure 20). I hoped
that the results (figure 21) would confirm the original results and that a higher
concentration might result in a more complete knock-down of Lhx5. Additionally,
a genomic control was added where primers were run on fin-clipped genomic
DNA samples as opposed to WT cDNA. This control tested for whether the PCR
conditions were able to generate a product of the size of the unspliced RNA
product as well as whether there was genomic contamination in the samples. The
gel suggested that some splice-blocking might have occurred with the lhx1a MO
2.5µg/µL and 3µg/µL injections. A second band started to appear that was the
same size as the un-spliced genomic control. However, there were also similar
second bands in the controls with lhx1b primers suggesting that the secondary
bands seen in both the experimental and control might be the result of genomic
contamination. Genomic contamination can occur when preparing the RNA
before performing the RT-PCR. In this case, some genomic DNA might have
been carried through to the final RNA extraction and then used in the RT-PCR.
As such, a secondary band corresponding to the unspliced genomic control would
appear. With regards to the Lhx1b samples, secondary bands appeared in both the
1.0µg/µL and 2.5µg/µL injected cDNA samples. Since the control samples
appeared normal (did not have bands at the size of the genomic DNA), this
suggested splicing was being impacted in the samples injected with 1.0µg/µL and
2.5µg/µL of lhx1b MOs. The Lhx5 genomic control was not visible on the gel,
suggesting my PCR conditions were not correct to a get a band at the correct
length for the genomic DNA. Most importantly, the Lhx5 samples did not show
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the same reduction in band strength as was seen in the initial injection. This
suggested that either the original results or these results were incorrect perhaps
because of a difference in injection size, an error in extracting the RNA for the
RT-PCR, or a problem with the RT-PCR itself in either the first or second round
of injections.
Therefore, I performed a third injection experiment to see if increasing the
concentration of lhx1a MO would result in a more significant knock-down and to
test which of the different results from injecting lhx5 MO was more likely. The

Figure 22. Third and final injection results with Lewis MOs. Lanes 1, 6, and 11 indicate
genomic controls. Lanes 3 and 5 indicate control lanes for lanes 2 and 4, respectively.
This is because lane 3 is lhx5 primers on lhx1a S-B MO injected which essentially tests
the viability of the cDNA. Lanes 7 and 9 are control lanes for lanes 8 and 10,
respectively.

results are depicted in figure 22. By increasing the extension time, the lhx1a
genomic control band became stronger. Unlike in the second experiment, the
lhx1a injected samples did not demonstrate any knock-down. In this round of RTPCR, the Lhx5 genomic control was visible. However, the spliced versus genomic
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unspliced bands were almost identical in size which would make it hard to tell
whether splicing had been blocked in an experimental sample. Finally, the results
of the Lhx5 injections were consistent with what had been seen in the second
experiment, namely that no significant knock-down was visible. Lhx1b injections
were omitted in this round because the lhx1b mutant was successfully genotyped
around this same time, eliminating the need to knock-down the transcription
factor via injections.
As I hypothesized that Lhx1a/Lhx1b/Lhx5 might act redundantly and I
might need to knock down all 3 genes to see a phenotype, I injected lhx5 and
lhx1a S-B MOs together to test whether the combination of the two at their
highest previously injected concentrations would be lethal to the embryos. Since I
had not seen a loss of splicing at these concentrations, I knew that I would have to
increase the concentrations of each of these MOs individually; however, if the
embryos died when the MOs were combined at their current concentrations then
there was no point in continuing to increase the dosage. This is because I wanted
to ultimately inject the MOs together to see a complete knock-down of Lhx1/5. In
these injections (done twice) 95.0-100.0% of embryos died (see table 5).
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Table 5. Injection results when lhx1a and lhx5 MOs were injected together.
MO Injected

Concentration

Number Injected

Number Dead

lhx1a and lhx5

lhx1a: 4.5µg/µL

35

100% (35)

40

95.0% (38)

lhx5: 3.5µg/µL
3 nl injected
lhx1a and lhx5

lhx1a: 4.5µg/µL
lhx5: 3.5µg/µL
3 nl injected

Because those injections killed the embryos, I tried a new lhx5
morpholino. This was a MO that had previously been used by Peng and
Westerfield (2006). They found that when this lhx5 S-B MO was injected the

Figure 23. Initial injection results with Westerfield lhx5 MO. Lanes 1 and 2 are genomic
controls. Lane 2 is weaker because this sample requires a longer extension time. Lanes 4,
6, and 8 are control lanes because they have lhx1a primers on lhx5 S-B MO injected
samples. Lanes 3, 5, and 7 are experimental and have lhx5 primers on lhx5 S-B MO
injected. As indicated by lanes 3,5 and 7, the bands become weaker as the concentration is
increased. This suggests that splicing is being blocked.

embryos did not have rostral head structures and had misshapen posterior head
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structures (Peng and Westerfield, 2006). In my previous injections, I had never
seen any morphological phenotypes. Therefore, I thought that this Peng and
Westerfield S-B MO which had previously resulted in such visible effects might
be a better choice for my research. Based on Peng and Westerfield 2006, the
initial concentration that I injected was slightly higher than that of the other MOs.
In the first injection, both genomic controls appeared visible and identical to those
previously seen in the other injection experiments. Furthermore, as the
concentration of injected MO increased from 4.0µg/µL to 6.0µg/µL, there
appeared to be a visible change in the band strength, suggesting that the levels of
spliced RNA were being reduced (figure 23). In addition to the PCR results from
this round of injections, I observed some morphological phenotypes in injected
embryos at 24 hours post-fertilization. The embryos were necrotic with misshapen
heads and eyes which was similar to Peng and Wsterfield who saw that lhx5 MO
injected embryos have smaller eyes and heads (Peng and Westerfield, 2006). This
necrosis was most significant in the heads of the embryos. Retrospectively, it may
have been a good idea to inject the new lhx5 S-B MO in combination with a p53
MO; however, I did not initially do this as Peng and Westerfield had only injected
the lhx5 S-B MO by itself. The somites in the tails were also not well-defined.
Most notably, the tails were visibly kinked backwards. Finally, and interestingly,
the embryos were hardly moving as compared to the wild-type controls.
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To confirm my findings, I conducted a second round of injections with
this new MO. This
time, the highest
concentration (6.0
µg/µL)

used

previously

was

reinjected as well
at
Figure 24. Second injection results with Westerfield lhx5 MO. All
samples were injected with lhx5 S-B MO. The letter in parentheses
indicates the primers used. For example, 6.5μg/uL (5) means that
lhx5 S-B MO was injected and lhx5 primers were used.

two

higher

concentrations,
6.5µg/µL

and

7.5µg/µL. The

results as shown in figure 24 confirmed the initial findings: the splicing of lhx5
seemed to be at least partially blocked. The complete absence of longer bands in
figure 24 might be because the PCR conditions were not ideal for the longer,
unspliced PCR product. A second possibility is that when splicing is blocked this
can make some RNAs less stable. In these cases, the RNA is present transiently
and is unstable, possibly because this longer length is targeted for degradation.
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As with the previous injection
round,

I

observed

morphological

phenotypes. The embryos appeared
identical to those in the previous
injections with the new lhx5 MO.
Again, the most notable phenotypic
changes were necrosis and misshapen
heads along with the tail kinked
backwards (figure 25).
When I injected the lhx5S-B

Figure 25. Morphology of WT vs. lhx5 S-B MO
injected. Embryos at 24 hpf. The lhx5 S-B MO
injected embryo has a stunted, kinked tail
and misshapen head structures.

MO a fourth time, I repeated the 7.5µg/µL concentration and also increased the
concentration to 8.3µg/µL in order to see if the knock-down would be more
severe. Table 6 shows the results of my fourth round of injections.
Table 6. Results of fourth round of lhx5 S-B MO Injections.
MO
Injected

Concentration

Number
Injected

Number
Dead

Phenotypes/Comments Control

lhx5
MO

7.5µg/µL

55

14.5%
(8)

85.5%
(47)
had N=20;
misshapen heads and looked
somites, had kinked WT
tails.

lhx5
MO

8.3µg/µL

44

63.6%
(28)

36.4%
(16)
had N=18;
misshapen heads and looked
somites, had kinked WT
tails.

3 nL injected

3 nL injected
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I also conducted an RT-PCR in order to assess whether the lhx5 MOs
knocked-down

Lhx5

(figure 26). My results
from

this

RT-PCR

suggest

that

when

injected

with

higher

concentrations of lhx5 SB MO that splicing is
completely blocked. As
seen in figure 26, the Figure 26. RT-PCR on final injection round with highest
lanes with samples from
injected embryos have no
bands while those acting
as positive controls still

lhx5 MO concentrations. In (control samples in lanes 1
and 3) where lhx1a were used on lhx5 S-B MO injected
samples there are still bands representing splicing.
However, in (2 and 4) which are lhx5 S-B MO injected
samples with lhx5 primers, there is a visible reduction
(an absence in this case) of the bands, suggesting that
splice was blocked. Finally, the genomic sample (lane 5)
shows up normally, demonstrating that the lhx5 primer
is working appropriately.

have bands. This shows
that spliced RNA was eliminated in the experimental lanes. I used some of these
injected embryos in an in situ to assess the impact of injections on
neurotransmitters throughout the spinal cord and within the CiA cells in
particular. However, the in situ was unsuccessful.
After the in situ was unsuccessful, I decided to inject a final time in order
to conduct another in situ. In this round, I again injected 8.3µg/µL of lhx5 S-B
MO. However, unlike in previous injection rounds, I injected into the lhx1b
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homozygous mutant which finally laid embryos in addition to WT embryos.
Although the lhx1b mutant finally laid embryos that I could use in an experiment,
all of these injected embryos subsequently died. It should be noted that I only
saved two of these lhx1b mutant embryos to use as a control. Because only 24
embryos were laid (table 7), I was eager to use as many as possible for my actual
experiment. Although these two control embryos survived, I cannot be completely
sure whether the death was due to my injections or because these mutant embryos
were sick prior to my injections. I could only be sure if I had more embryos as a
control. Furthermore, many of the WT injected embryos also died. In the previous
round of injections with 8.3µg/µL of lhx5 S-B MO, 63.6% (table 6) of the
embryos died compared to the 88.2% (table 7) that died this time. The increased
number of dead embryos could be due to the fact that I injected more embryos
during this last injection round or that the concentration was actually a bit higher
than I thought. The surviving embryos from this injection were used in an in situ.
Table 7. Results of final round of injections with lhx5 S-B MO.
MO
Concentration
Injected
and fish
line

Number Number Phenotypes/Comments Control
Injected Dead

lhx5 MO 8.3µg/µL
into lhx1b
3 nL injected
mutant

22

100.0%
(22)

All embryos died.

N=2;
appeared
normal

lhx5 MO 8.3µg/µL
into WT
3 nL injected

102

88.2%
(90)

Embryos displayed the
same phenotypes as
my other injected
embryos (kinked tails
and misshapen heads).

N= 40;
all
appear
WT
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Analyzing expression of Pax2 and Neurotransmitter Markers in embryos with
reduced Lhx1/5 function
I did an in situ on the embryos injected with 3.02 µg/µL each of lhx1a,
lhx1b, and lhx5 S-B MO and 3.84 µg/µL p53 MO. Unfortunately, these embryos
were rather fragile and did not make it through the procedure. This is likely
because they were in proteinase K too long. Proteinase K increases the
permeability of the membranes in the embryo so that the probes can enter the cells
and bind to RNA. However, if left too long, the proteinase K can make embryos
fragile. The amount of time I used was appropriate for WT embryos, but if the
injected embryos were more fragile to begin with, it may have been too long for
them. When I completed the in situ and went to analyze the results, I found that
none of the embryos had made it through the protocol. Instead, I found pieces of
the embryos and yolks. This is why I think that the proteinase K time was too
long.
I also performed an in situ on my embryos injected with 7.5µg/µL lhx5 SB MO as well as on the embryos from my most recent RNA injection (table 3). In
this in situ, I used two glycinergic markers, glyt2a and glyt2b, which correlate
with transporters that are required to reuptake glycine (Higashijima et al, 2004).
Based the aforementioned work in the mouse (Pillai et al., 2007), I hypothesized
that Lhx1/5 might be required to specify an inhibitory neurotransmitter fate in
CiAs which could be tested using the glyt2a and glyt2b as they are inhibitory
markers. Additionally, I utilized a pax2.1 probe which encodes for the pax2.1
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transcription factor (Pfeffer et al., 1998). However, the staining that appeared in
my in situ was nonspecific and primarily background. This meant that the probes
had not worked and consequently I had no results from this in situ.
As such, I performed a final in situ hybridization with a pax2.1 probe that
had been kindly prepped and provided by another student in the Lewis lab, Gisella
Rodriguez-Larrain. I chose to use this probe because I knew that it had worked for
Gisella in the past. I also knew this would be the last in situ I would have time to
perform. I hope that using a pax2.1 probe would enable me to answer the question
of how the Lhx1a/1b/5 and Pax2/8 families of transcription factors interact in the
zebrafish spinal cord. Furthermore, I was attempting to answer whether Lhx1/5
and Pax2/8 maintain one another. As such, I expected to see a difference in the
number of pax2.1 expressing cells in the WT as compared to the control. The
small dots, most clearly seen in figure 27C, are actually individual cells that
express Pax. Figure 27C demonstrates that the in situ was successful because
specific staining can be seen in individual cells throughout the spinal cord.
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Figure 27. pax2.1 in situ results on WT compared to injected embryos. (A) and (B)
were kindly provided by Dr. Lewis. (A) indicates the portion of the spinal cord that
our lab analyzes. The red dotted lines surrounds the midline and extends upwards
towards the most ventral cell populations. (B) is a cross-section of the spinal cord and
indicates the location of the spinal cord relative to the somites and notochord in the
zebrafish. In pictures (C) and (D), embryos from the in situ I performed are situated
with their heads towards the left and their tails to the right. (C) is a picture of a WT
embryo I used in my in situ with the pax2.1 probe. The black line indicates the midline
of the embryo. This picture was taken at 40x magnification. This picture was included
to demonstrate that the probe had in fact worked and to show what an ideal picture of
an in situ looks like. If my injected embryos had been less fragile, I would have taken a
similar picture with them. (D) is a comparison between a lhx5 S-B MO injected embryo
and a WT both with the pax2.1 probe. The orientations of the embryos are slightly
different, but I included this picture so that the obvious differences in the amount of
cells expressing pax2.1 could be visualized. The orientation was unable to be changed
because the injected embryo continued to deteriorate as I tried to reorient it. (D) was
taken at 10x magnification.

The embryos I used in this in situ were particularly fragile as they had
been injected with 8.3µg/µL lhx5 S-B MO and their heads and tails were
misshapen, as shown in figure 25. As such, these embryos made it through the in
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situ protocol, but when I was removing the yolk to take pictures, I found that the
embryos deteriorated and were especially hard to mount to take a picture.
Consequently, figure 27D is not ideal, but still shows that the number of cells
expressing Pax in the lhx5 S-B MO injected appears to be significantly less than
in the WT control. This was the case for all five lhx5 S-B MO injected embryos
that made it through the in situ. The results from my in situ suggest that Lhx1/5
are related to Pax2/8 in the zebrafish spinal cord which is a novel finding. Based
on the fewer Pax2/8 expressing cells seen in figure 27D, it is possible that Lhx1/5
help to maintain Pax2/8 expression in the spinal cord. This experiment will need
to be repeated so as to obtain a more ideal picture and to conduct actual cell
counts. Counting the cells within the spinal cord will enable us to quantify the
difference that I believe can be seen in these pictures (figure 27D). Although this
experiment would need to be repeated and cell counts would need to be done, this
is an exciting result because the effects of knocking-down Lhx5 on Pax2/8 in the
zebrafish spinal have never been studied and it was unknown whether Lhx1/5 and
Pax2/8 were related in the zebrafish spinal cord.
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Discussion
lhx1b Mutant
Initially, we were unaware that the lhx1b fish sent to us from the Sanger
institute were the progeny of a heterozygous incross as the usual practice is to
send an outcross of a heterozygote. Therefore, it seemed surprising when my PCR
results suggested that one of the adult fish from this line that I identified was a
homozygous mutant. We were concerned that this result might have been due to a
false positive, with the restriction enzyme not cutting the DNA (because WT
DNA should cut and mutant should not). However, sequencing revealed that this
fish was indeed a homozygous mutant. This is an exciting result as it shows that
the lhx1b mutation is embryonic viable.
By creating a PCR and restriction enzyme protocol to identify the lhx1b
mutants, I established a way to identify lhx1b mutants in the future and accurately
separate homozygous and heterozygous fishes from wild-type, without having to
send DNA from each fish to sequence. However, given the risk of false positives
(if the DNA does not completely cut), it still might be worth sequencing identified
heterozygous and homozygous fish. This mutant line is especially valuable in that
it eliminates the need to inject lhx1b MOs or RNA constructs, making the knockdown of all 3 Lhx1/5 genes in zebrafish much easier to perform without
nonspecific toxic effects.
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Some of the fish that I identified as wild-type might actually be
heterozygous for the lhx1b mutation as they have a weak longer (“mutant like”)
band (example lanes 6 and 11 figure 16). Fish that had any ambiguity were
compared to the known WT control. In several instances the WT control fish also
demonstrated weak longer bands (as seen in the last lane with a WT sample in
figure 16). This could be because of an incomplete digest in the reaction which
might occur if there is an excess of DNA, leading to the presence of a second
uncut band. Therefore, fish with a weaker longer band were considered WT and
fish were only identified as heterozygous if they had two distinct bands, with both
exhibiting equal brightness. In the case where a “WT” fish had a second band, the
shorter band was clearly more distinct than the longer, consistent with the idea
that a small amount of DNA did not cut. Interpreting the results in this way has
the advantage that we are less likely to wrongly identify a wild-type as a
heterozygous mutant, which could have dire consequences for our experiments. If
the bands are not equally strong, then I identified the fish as a wild-type.
Misidentifying wild-type fish as heterozygous would be much more detrimental
that misidentifying a heterozygous fish as WT because if we use a WT fish in an
experiment where we thought we were using a lhx1b heterozygous mutant then
lhx1b would not actually be knocked-down. While misidentifying a heterozygous
fish as a WT fish would be a loss because it would mean I have fewer mutant fish
to work with, I would not be compromising my experiments. In addition, the
sequencing results as well as the results of the chi square test demonstrate that this
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rationale for distinguishing between WT and heterozygous fish was probably
accurate.
RNA fusion constructs as a method of impacting Lhx1/5expression
This portion of the experimentation was perhaps the most frustrating in
that the injections appeared to be yielding significant results, but then I found out
that the enzyme used initially, BamHII, was cutting in the incorrect location. The
fact that I still saw phenotypic effects from the injections can be attributed to a
variety of possible causes. It is possible that the injected RNA still had either
partial function or dominant active or dominant negative function and, therefore,
was managing to have some effect on the embryos. However, it is more likely that
the RNA injected was simply sickening the embryos and had no specific effect on
any of the Lhx1/5 transcription factors. At times, injections can be toxic to
embryos simply on the basis that too much foreign material is being introduced.
When the correct enzyme was used to linearize the DNA, the embryos
mainly appeared morphologically WT. This suggested that either there might be
an issue with the RNA itself or there might not be any morphological effect from
interfering with Lhx1/5 activity. However, given that the literature suggested that
injecting fusion constructs did result in phenotypic changes to the embryos, I
remade the RNA. Unfortunately, the injection results from the newly prepped
RNA contradicted one another. In one round, there appeared to be a
morphological phenotype whereas the second injection round yielded no
morphological phenotype. It is possible that these findings actually recapitulate
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the earlier findings, with the first RNA synthesis with the correct restriction
enzyme, that the RNA fusion construct had no morphological effect, meaning that
there was nothing “wrong” with that RNA after all. However, it is also possible
that the second injection experiment was anomalous and that there is a real effect.
A reason for the anomaly could be if I introduced an RNAse (RNA-degrading
enzyme) into the RNA injected thereby degrading the RNA. Furthermore, it is
theoretically possible that I pipetted inaccurately and therefore injected a different
amount of RNA than calculated. The results from the third injection round (table
3) were consistent with the second round in that the embryos did not exhibit a
morphological phenotype. Based on these results, I concluded that either these
injected RNA concentrations do not cause a morphological phenotype and the
effect can only be seen via in situ hybridization or that the concentration must be
increased to achieve a phenotype. Although I performed an in situ on the RNA
injected embryos to assess whether the former or the latter was the case, the in
situ was unsuccessful and failed to yield any specific staining. As such, the
injections will need to be performed again and another in situ conducted in order
to assess the effects of injecting this RNA construct on Lhx1/5.
ATG MOs as a tool for knocking-down Lhx1/5function
The embryos obtained from the ATG MO injections were quite fragile.
Even once the middle concentration was injected, the surviving embryos were
visibly disturbed and exhibited distorted head structures, misshapen tails, and
slight necrosis. However, I dechorionated them and put them through the in situ
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protocol. Despite my best efforts, the embryos did not make it through the in situ
and only the yolks were left at the end of the experiment. This suggested that the
proteinase K time should have been reduced so as to allow the probes to
permeate, but reduce the impact on the embryos themselves. Although I did not
have time to return to the ATG MOs before completing my thesis, this area is
certainly one that should be addressed by another researcher in the future.
S-B MOs as a method for impacting Lhx1/5expression and function
When injecting the original S-B MOs, as these had not been used before, I
chose to inject at higher concentrations and titrate down so as to more easily
discover the maximum effect that the morpholino might have. If I had initially
tried a low concentration and had not seen splice blocking it would have been
necessary to increase the concentration until all of the embryos died in order to
determine the maximum dose and most severe effect. Furthermore, I injected each
of the three MOs (lhx1a, lhx1b, lhx5) individually in order to be sure how much
was required to inhibit splicing of each individual transcription factor gene before
combining them. However, I also injected the two MOs together knowing that
the amount required to knockdown the function of one transcription factor might
be too toxic when combined and injected with the other two MOs. This was in
fact the case when two splice-blocking MOs (lhx1a and lhx5) were injected
together at the maximum single injection experimental concentrations that I had
tried. As the mix of all two was lethal to the embryos and yet for lhx1a and lhx5 I
had not seen an effect on splicing at these concentrations, I tried switching to
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another lhx5 S-B MO that had been reported to work (Peng and Westerfield,
2006). I tried this MO initially at concentrations suggested by Peng and
Westerfield and therefore did not try the method I had used for the other S-B MOs
where I titrated the concentration.
In my RT-PCR experiments I had very variable results. There are several
possibilities for these inconsistencies. With regards to the morphological
variation, one possible reason is that knocking down a single transcription factor
might have variable or even imperceptible results because the other two
transcription factors act redundantly and could compensate for the loss. However,
this applies only to morphological phenotypes. Other reasons may account for the
differences in splice-blocking PCR results. For example, I hypothesized that the
PCR band for the RNA in question might get longer or a second unspliced band
might appear if RNA splicing was blocked. This is because splice-blocking means
the introns are not removed and the RNA product is therefore longer.
Consequently, the product would run at a different position on the gel.
Alternatively or in addition, the WT band might appear fainter, or disappear
completely if inhibiting of splicing caused the RNA to be unstable. Another
possibility was that the gel might appear blank. This could have been the result of
several possibilities. First, the primers might not have worked in the PCR,
resulting in a lack of product. Second, one of the reagents in the RT-PCR might
not have worked or splicing was blocked and the RNA was targeted for
degradation. To try and distinguish between these possibilities, I ran a positive
control in parallel to each experimental sample in order to fully understand the

70

results. In order to control for the first possibility in particular, I ran two separate
reactions with each cDNA sample. In each case, the corresponding primer set was
used (if I injected lhx5 MO then I used lhx5 primers), but a second reaction was
also run in which another set of Lhx primers was used as a control to test that
cDNA was present. I expected that a band would always appear on the gel in the
lane representing where the non-corresponding primer set was used as this region
should be able to be amplified and should never be knocked down in the absence
of the corresponding MO.
My initial MO injection results seemed promising, suggesting a partial
knock-down of lhx5. However, the second and third experiments were not
consistent with this finding. It is possible that the results seen in the first injection
round were actually the result of some contamination that impacted cDNA
synthesis. If something had damaged the sample, the band on the gel might appear
weaker even if the MO was not knocking-down lhx5. However, arguing against
this explanation, the control bands appeared normal and the effect seemed to
become more significant as the concentration was increased. These anomalies can
perhaps be attributed to some other error in the PCR. The absence of any apparent
knock-down in the subsequence two experiments suggested that the possible
knock-down observed in the first injection was not a true reflection of the effect
of the MO. This demonstrated the importance of repeating experiments to check
that the results are reproducible.
With regards to lhx1a, it looked like when I injected a higher
concentration in the second round of injections a knock-down might be occurring.
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However, when the 3.5µg/µL concentration was repeated in addition to a higher
(4.5µg/µL) concentration, the results showed otherwise. This suggests that the
results seen in the second injection round were in fact not accurate. It is possible
that some of the samples were not completely inserted into the wells of the gel
and instead settled in neighboring wells. This might also explain the presence of
secondary bands for the control samples in the second injection round. Moreover,
it is possible that these samples were contaminated with genomic DNA. As such,
it was concluded that the lhx1a MOs did not have a significant effect on Lhx1a
splicing.
Finally, when I increased the concentration of Lhx1b in the second round
of injections, it appeared a knock-down was occurring. This was perhaps the
strongest instance of a possible knock-down as the second bands were appearing
at the un-spliced genomic size and no longer bands were seen in the control
samples. The absence of longer bands in the control sample shows that there was
no genomic contamination. Moreover, the band corresponding to the spliced
lhx1b sample was more decreased in the 2.5 µg/µL injected sample than in the 1.0
µg/µL sample. This suggests that as the concentration of injected MO was
increased the splicing was further inhibited. Furthermore, the secondary bands
corresponding to the un-spliced lhx1b samples were at the same size as the unspliced genomic control for lhx1b. Although the results looked promising, the
lhx1b MO was not injected during the third round of injections because I had
successfully genotyped the lhx1b mutant. Instead, I focused on finding the correct
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concentrations of the remaining two MOs. Regardless, it appears that the 2.5
µg/µL injection of lhx1b was significantly impacting lhx1b RNA splicing.
Because the embryos all died when I injected a mix of lhx1a and lhx5 S-B
MOs at their highest tested individual concentrations (table 5), I decided to try a
new MO. The reason that 2 embryos lived (table 5) might suggest that these
embryos received a smaller injection or that they were on the side of the dish and
had accidently not been injected at all or that less of the MO had traveled from the
yolk into the embryo. Since all of the embryos died when I injected the mix of
lhx1a and lhx5 MOs, I tested a new lhx5 MO which was used successfully by
Peng and Westerfield (2006). The initial injection showed possible knock-down at
the highest concentration of 6.0µg/µL. Furthermore, the control samples showed
normal bands, indicating that the PCR reaction was working and the cDNA was
present. The reason for the weaker lhx1a genomic band in figure 19 is probably
that this longer PCR product requires a longer extension time. However, I omitted
the extended time because it had the potential to interfere with the results of the
other samples. Although the band is weak, it is visible.
My second round of injections with the new lhx5 MO confirmed my initial
findings. As compared to the controls, the 6.0 µg/µL, 6.5 µg/µL, and 7.5 µg/µL
experimental samples yielded weaker bands which indicated a knock-down effect.
Consequently, Lhx5 can be at least partially knocked-down with a MO injection
at a of concentration of 6.0-7.5µg/µL and a volume of 3 nl.
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Furthermore, as mentioned earlier, I also observed a visible phenotype in
these knock-down embryos which was a tail kinked backwards. Additionally, the
embryos exhibited severe necrosis in their heads which were misshapen with the
eyes and mid-brain hindbrain boundary not visible. The phenotype was significant
in that it resembled the findings of Peng and Westerfield (2006) who found that
Lhx5 S-B MO injections resulted in “embryos that lack the most rostral part of the
head [and] posterior head structures”. Moreover, MO injected embryos “later
develop small heads with small eyes,” a finding similar to my results (Peng and
Westerfield, 2006). The reason that I decided to try a new MO was because, as
stated previously, I thought it was key to knockdown all three genes together
given that they are expressed by the same cells and may act redundantly like
Pax2a/Pax2b/Pax8 (Gustavo Cerda-Moya, 2011; Batista and Lewis, 2008).
The results from my fourth round of injections (table 6) suggest that the
phenotype continues to get more severe as the concentration of lhx5 MO is
increased. More embryos died in this round of injections as well, suggesting that I
was approaching the upper limit for these injections. My results demonstrate that
the splice blocking does get more pronounced as the concentration is increased.
The bands corresponding to the WT spliced RNA in the injected embryos
completely disappeared as shown in figure 25 while the control samples yielded
normal bands on the gel. This means that the MOs successfully affected Lhx5
RNA splicing.
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In my final round of injections, I injected into lhx1b homozygous mutant
embryos (table 7). Until this point, the lhx1b mutant had never laid any embryos
for me to inject. Injecting into these embryos was exciting in that lhx1b was
already knocked-down and I therefore expected that the phenotype might be more
severe when I injected the lhx5 S-B MO. I expected this because, as previously
mentioned, Lhx1/5 are co-expressed in the same cells and therefore might act
redundantly (Cerda-Moya, 2011). All of the lhx1b mutant embryos died as a result
of my MO injections (table 7), suggesting that either the embryos were naturally
less viable because it was the first time I had gotten the mutant to lay or that the
concentration of injected MO was too high given that lhx1b was already knockeddown. However, it is also possible that fully knocking-down both Lhxlb and Lhx5
is embryonic lethal. This experiment would need to be repeated with varying lhx5
S-B MO concentrations in order to fully assess the reason these embryos died.
Analysis of gene expression in embryos with reduced Lhx1/5 activity
Although my original intention was to investigate the function/s of the
Lhx1/5 transcription factors, most of my time was spent testing various knockdown strategies. However, I did attempt to investigate the function/s of the
Lhx1/5 transcription factors through in situ hybridization. The first two in situ
experiments that I conducted were rather fruitless in their results. As mentioned,
in the first in situ many of my embryos were lost, possibly as a result of
subjecting them to proteinase K for too long which can damage already fragile
embryos. In the second in situ, I found that my probes failed to yield any specific
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staining which prohibited me from investigating gene expression in embryos with
reduced Lhx1/5 activity. However, my most recent in situ had significant results.
Although the pictures obtained were not ideal, I did see a reduction in the number
of cells expressing Pax2/8. The differences between the embryos injected with
8.3µg/µL lhx5 S-B MO and the WT embryos were drastic. This is exciting
because the results have the potential to recapitulate findings in the mouse that
indicated that Lhx1/5 help maintain Pax2/5/8 (Pillai, 2007). Furthermore, it
suggests that Lhx1/5 might have a similar function in the zebrafish. Additionally,
my findings suggest that there is a relationship between Lhx1/5 and Pax2/8 which
has never been investigated or proven in the zebrafish.
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Conclusion
My research has successfully assayed the tools available to knock-down
Lhx1/5 in order to test the function of these transcription factors in the zebrafish
spinal cord. One such tool was the lhx1b mutant line, which can now be
successfully genotyped using PCR and specially designed primers as well as a
restriction enzyme digest reaction utilizing the enzyme DraI. The ability to
identify lhx1b mutants is a novel contribution as is my discovery that this
mutation is not embryonic lethal. These discoveries have important implications
for future research on this topic in that fewer knock-down reagents will need to be
injected into the embryos in order to test the effects of knocking down all three of
the Lhx1/5 transcription factors. Ultimately, injecting fewer reagents should
reduce nonspecific toxic effects on embryos.
This project also significantly increased our understanding of how to
knock down the Lhx1/5 transcription factors. Previously, it was unknown which
were the best methods to employ. However, it now seems that Lhx1/5 MOs are
the best option. Although the ATG MOs yielded promising results, this direction
was not fully explored. However, with the results at hand, it currently appears that
splice-blocking MOs are the most efficient choice for knocking-down Lhx5. In
contrast, the RNA results at this point seem inconclusive. Experimentation with
RNA fusion constructs will also be repeated in the future. Finally, in situ
hybridization results suggest a relationship between Lhx1/5 and Pax2/8 in the
zebrafish spinal cord and that Lhx1/5 might be necessary in order to maintain
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Pax2/8. This result was novel as the exact relationship between Lhx1/5 and
Pax2/8 had never been explored in the zebrafish.
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Future Directions
Although my project yielded many useful results, there remains a great
deal of work to be completed before the questions are fully answered. One
potential direction would be to also utilize either GFP lines and/or noi (no-isthmus
mutation) fish lines to investigate the effects of knocking-down lhx1a/1b/5 on the
zebrafish spinal cord. The GFP lines would enable the examination of
morphological changes in specific interneurons within the spinal cord whereas the
noi line would allow for the study of the effects of knocking down the Lhx1/5 in
the absence of pax2a. To test whether Lhx1/5 and Pax2/8 have any independent
functions in specifying neurotransmitter fates, it would be necessary to also knock
down Pax2b and Pax8 and determine if the phenotype is more severe than either
Pax2/8 triple knock-down or Lhx1/5 triple knock down embryos. This would be
difficult to do without the embryos getting very sick as it would involve injecting
four different MOs. This would be an important experiment because of the
potential interactions of the Pax and Lhx transcription factor families. With
regards to injections, the lhx1a ATG MO would be an excellent place to continue
work as it is still not clear if this is an effective way of knocking down lhx1a or
not. Although, as this is an ATG MO, it is difficult to test this without an
antibody. Based on the findings mentioned briefly in this paper, there is the
potential that lhx1a ATG and lhx5 S-B MO injections into lhx1b mutants would
yield novel findings. In order to target all three genes, the lhx1a ATG MO could
be injected into the lhx1b mutant fish in combination with the lhx5 S-B MO that
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has already been shown to work. My results suggest that our existing lhx1a S-B
MO is not effective, but new S-B MOs for this gene could be tried. In terms of the
RNA fusion construct injections, the injection of Lhx5Vp16 and Lhx5GFP should
be tried as this could lead to significant findings. These constructs were never reprepped once the enzyme issue had been resolved as I ran out of time. Finally, the
most recent in situ experiment should be repeated with embryos injected with
8.3µg/µL of lhx5 S-B MO as compared to WT. This experiment will hopefully
recapitulate the aforementioned findings (figure 27C-D).
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Capstone Summary
Located in the vertebral column, the human spine is responsible for
controlling many bodily functions that healthy individuals take for granted. In
addition to regulating standard body movements and organ operations, the spinal
cord receives sensory input from the rest of the body about pain and touch.
Various neurological conditions including neuro-degeneration as well as spinal
cord injuries result in deficits in these functions. These types of ailments are
particularly common. A recent survey estimated that 183,000-230,000 people in
the United States alone suffer from spinal cord injuries (NIH Medline Plus).
Furthermore, approximately 11,000 new cases of spinal cord injury present each
year in the United States alone (NIH Medline Plus). Oftentimes these injuries are
the result of accidents, violence, and sports-related injuries and happen to people
in the prime of their life (NIH Medline Plus). Currently, there are few treatments
for these conditions, partly because we know very little about how a fully
functioning spinal cord is constructed. This means that studying spinal cord
development, specifically neuron specification and patterning, the subject of my
thesis research, should ultimately be useful for developing better treatments for
people with spinal cord injuries and diseases.
Zebrafish are a prime model organism in which to study spinal cord
development for a number of reasons. Most simply, zebrafish are a relatively
inexpensive choice when compared to other standard vertebrate model systems
like mouse and a large quantity of embryos can be easily obtained from adult fish
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without harming the parents. In addition, zebrafish have transparent embryos that
grow rapidly outside of the mother. These characteristics allow us to examine
central nervous system (CNS) development, including spinal cord development,
in live embryos.
Zebrafish are also a useful model organism because the cell shape
(morphology) of individual nerve cells (neurons) can be examined in live
embryos. Neurons are the communicating cells of the CNS. Interneurons are a
type of neuron that helps to relay messages between other neurons and they are
essential components of most CNS neuronal circuits. My project has focused on
interneurons. In zebrafish embryos, interneuron morphology can be examined by
labeling specific cell types with fluorescent proteins such as GFP. This is difficult
to do in mammals because the embryos develop inside the mother and are not
transparent. It is easier to study interneurons and identify them as a particular cell
type with a specific function in zebrafish. This is because, in addition to it being
easier to visualize individual interneurons in the externally-developing transparent
zebrafish embryos, the zebrafish spinal cord has relatively few different types of
interneurons in comparison to mammals. Furthermore, each interneuron type can
be easily recognized by its particular morphology. For example, the interneuron
type studied in my research, CiAs, have a distinct interneuron shape which
distinguishes them from the others. In addition to the unique morphologies, each
interneuron type has a distinct neurotransmitter fate. Neurotransmitters are the
chemicals within the central nervous system that help neurons to communicate.
Finally, it is easy to knock down individual gene functions with mutants and other
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methods in zebrafish, which was particularly important for my project. Various
reagents can be injected into an embryo via a thin needle in order to knock-down
gene function. The transparency and rapid development of zebrafish embryos
enables this experimentation to be conducted relatively easily.
My project focused on V1 neurons which form in the ventral (abdominalside) spinal cord. In zebrafish, V1 cells, which regulate/enable fast movement,
develop into CiAs or Circumferential Ascending interneurons (Goulding, 2009).
During spinal cord development, individual cells take on a particular identity
depending on their location in the spinal cord. Based on this cellular identity, the
cells have unique characteristics and functions and later develop into distinct
interneuron types. For instance, distinct ventral interneurons control different
aspects of movement in the zebrafish
CiAs have several functions including motor control and sensory gating.
Sensory gating is the ability to screen for irrelevant sensory input and prevent it
from interfering with other neurological processes (Burgess and Granato, 2007).
Various research projects have already been conducted with V1 cells in other
organisms such as frogs and mice. Results from tadpoles demonstrated that the
cells correlating to CiAs and V1 cells, called aINs in frogs, are implicated in
swimming behaviors and sensory gating (Li, et al., 2004). Similarly, V1 cells in
mice are required for faster movements. When V1 cells were ablated, mice had
difficulty moving at faster speeds although movement was still possible
(Gosgnach et al., 2006). The CiA cells in zebrafish are functionally similar to the
V1 cells seen in mammals (Higashijima, 2004), which makes them an appropriate

86

choice for study considering my goal of aiding in the treatment of spinal cord
injuries in humans.
Each interneuron type expresses a unique combination of transcription
factors. Transcription factors are proteins that bind to DNA and either promote or
inhibit expression of particular genes. Therefore, investigating the roles of
transcription factors is key to better understanding how interneuron characteristics
are genetically specified. Several transcription factors are expressed consistently
in all vertebrate V1 cells and my research focused on a few of these, namely
Lhx1a, Lhx1b and Lhx5 (often referred to here as Lhx1a/Lhx1b/Lhx5). My main
questions were: What are the best reagents to test Lhx1a/1b/5 function? Can I
identify ways to work with a new Lhx1b mutant line? and What is/are the
function/s of Lhx1a/1b/5 in the zebrafish spinal cord? In order to answer these
questions I had to use a variety of experimental techniques.
In my research project I primarily used morpholinos (MOs) and RNA
fusion constructs to knock-down the function of specific transcription factors.
Morpholinos are synthetic agents that mimic the actions of real RNA; however,
whereas RNA is the template for creating proteins, MOs stop the production of
protein. RNA fusion constructs are RNA that has been made from DNA that can
be injected into an embryo. This RNA can either enhance or repress the
expression of normal genes because it acts as the new template for creating
proteins. Both MOs and RNA fusion constructs are reagents that can be injected
into the zebrafish embryo to knock-down specific protein functions. To “knockdown” function in these cases, means to eliminate or reduce the presence or
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activity of a particular protein. By knocking-down Lhx1a/1b/5, I aimed to assess
what their functions were within the spinal cord because the processes and/or
gene expression that they control should theoretically be stopped in their absence.
I then used a specific experiment called reverse transcription polymerase chain
reaction (RT-PCR) to determine whether the transcription factors had indeed been
knocked-down. RT-PCR is a molecular biology tool that enables the creation and
amplification of DNA from RNA and it can be used, as it was in this case, to
assess the expression of certain RNAs (and therefore, by inference, the expression
of the proteins encoded by those RNAs). Finally, I used in situ hybridization to
examine the effects of reducing Lhx1/5 function in the spinal cord. in situ
hybridization is an experiment that identifies which cells are expressing particular
genes. I also utilized the molecular biology technique of polymerase chain
reactions (PCRs) to identify lhx1b mutants, which are fish in which the lhx1b
gene is mutated and therefore inactive. Similar to the RT-PCR explained above,
PCRs are a molecular biology tool used to amplify specific regions of DNA.
However, in this case, DNA, not RNA, is used as the initial template.
My research demonstrated that certain reagents, namely MOs, are more
effective for knocking-down Lhx1/5 in the zebrafish spinal cord than RNA fusion
constructs. I also developed a way to successfully identify lhx1b mutants.
Developing a method to successfully identify lhx1b mutant fish is important
because it eliminates the need to knock-down lhx1b with reagents such as
morpholinos or dominant negative constructs, which are inherently more variable
and more likely to have non-specific effects than a mutation. These results are
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important because they will enable future researchers to perform more in depth
experiments concerning the function of these transcription factors. Without a
successful knock-down, neither I nor anyone else would be able to ultimately
investigate the function of Lhx1/5. With a better understanding of the knockdown reagents comes the ability to determine the functions of Lhx1/5. Being able
to better understand these transcription factors and the roles they play in the spinal
cord has the potential to translate into important medical applications to help
spinal cord regeneration. Preliminary data suggests that Lhx1/5 are involved in
maintaining another family of transcription factors, Pax2/8. However, this
relationship will need to be further investigated and other experiments will need
to be performed to fully understand Lhx1/5 function.
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